Abstract
We have found that N-isopropylmethoxarnine (IMA) and methoxamine are not typical beta adrenergic receptor blocking agents. They differ from dichloroisoproterenol (DCI) and nethalide in that they do not block any of the responses to beta adrenergic receptor activation in the anesthetized dog. However, in the isolated rat uterus, IMA and methoxamine produce a blockade of the catecholamine induced inhibitory response that is specific and that resembles closely the blockade produced by DCI and nethalide.
We have previously reported that the rat uterus possesses only beta adrenergic inhibitory receptors. IMA and methoxamine have also been reported to produce a blockade of the catecholamine induced increase in glucose and free fatty acids. This is a blockade that is also produced by the classical beta adrenergic receptor blocking agents DCI and nethahide. Two possible explanations are cited. First, IMA and methoxamine might be considered to be more specific beta adrenergic receptor blocking agents than DCI and nethalide in that they block beta adrenergic receptors only in certain tissues. Second, the receptor of the rat uterus is a different type of beta adrenergic receptor in that it is blocked by IMA and methoxamine as well as DCI and nethalide.
- The Williams & Wilkins Comapny
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|